Scratch2 Inhibitors
Chemical inhibitors of Scratch2 can achieve functional inhibition through various cellular and biochemical pathways. Alsterpaullone targets cyclin-dependent kinases (CDKs), impairing the cell cycle progression signals that can activate Scratch2, thus leading to its reduced activity. Similarly, Ro-31-8220, by inhibiting protein kinase C (PKC), can decrease the phosphorylation level of Scratch2, which is often a prerequisite for its transcriptional activity. Go6976, another PKC inhibitor, more specifically inhibits PKCα, which can phosphorylate transcription factors, resulting in decreased Scratch2 activity due to the lack of necessary phosphorylation. LY294002, by inhibiting PI3K/Akt signaling, leads to reduced Scratch2 activity as this pathway is involved in the regulation of various transcription factors. SB203580 and PD98059 obstruct the MAPK pathway at different points; SB203580 inhibits p38 MAPK, and PD98059 targets MEK, both of which can regulate Scratch2 activity through phosphorylation.
In the second part of the inhibition spectrum, SP600125, a c-Jun N-terminal kinase (JNK) inhibitor, can reduce Scratch2 activity by impeding the phosphorylation of transcription factors, which JNK can mediate. Y-27632's inhibition of ROCK, which plays a role in transcription factor regulation, can lead to reduced Scratch2 activity. Wortmannin's inhibition of phosphoinositide 3-kinases also reduces Scratch2 activity by preventing activation signals that may regulate transcription factor functionality. U0126, by inhibiting MEK1/2, decreases Scratch2 activity by halting the ERK pathway, which is known for its regulatory role in transcription factor activation. KN-93 specifically inhibits CaMKII, which can affect transcription factor activity, thus leading to decreased Scratch2 activity. Lastly, GF109203X targets protein kinase C isoforms, which, upon inhibition, can lead to reduced Scratch2 activity due to the decreased phosphorylation of transcription factors that PKC would typically mediate.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone inhibits cyclin-dependent kinases (CDKs), which are essential for cell cycle regulation. Since Scratch2 is a transcription factor that can be regulated by cell cycle signals, inhibition of CDKs by Alsterpaullone can lead to reduced Scratch2 activity by preventing the cell cycle progression signals that activate it. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
Ro-31-8220 is a potent PKC inhibitor. Protein kinase C (PKC) can phosphorylate a broad range of substrates, including transcription factors. Inhibition of PKC can decrease the phosphorylation and thus the activity of Scratch2, as phosphorylation is often required for transcription factor activity. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Go6976 specifically inhibits Protein Kinase Cα (PKCα). As PKCα can phosphorylate transcription factors and influence gene expression, Go6976 can decrease Scratch2 activity by preventing its necessary phosphorylation for activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3k inhibitor that reduces the activity of the PI3K/Akt signaling pathway, which is involved in the regulation of transcription factors. By inhibiting this pathway, LY294002 can lead to a reduction in Scratch2 activity, as PI3K/Akt can modulate transcription factor functionality. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. The p38 MAPK pathway can influence transcription factor activity by phosphorylation. Inhibition of p38 MAPK by SB203580 can therefore lead to decreased Scratch2 function, as p38 MAPK can regulate transcription factor activity through phosphorylation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which is upstream of ERK in the MAPK pathway. ERK can modulate transcription factor activity, so inhibition of MEK by PD98059 can lead to reduced activation of Scratch2, which may be regulated by the MAPK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which can phosphorylate transcription factors as part of cellular signaling. Inhibition of JNK by SP600125 could reduce Scratch2 activity, as JNK can influence transcription factor functionality and activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK, which is involved in a wide range of cellular functions including regulation of transcription factors. By inhibiting ROCK, Y-27632 can decrease Scratch2 activity, as ROCK can directly or indirectly influence transcription factor activity within cells. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases. By inhibiting these kinases, Wortmannin can lead to a decrease in Scratch2 activity by preventing the activation signals that are mediated through PI3K pathways which may regulate transcription factor activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, which are upstream activators of the ERK pathway. Since this pathway can regulate transcription factor activity, inhibition of MEK by U0126 can lead to a decrease in Scratch2 activity by preventing its activation through the ERK signaling pathway. | ||||||